Apollon Wealth Management’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-5,259	Closed	-$399K	–	773
2021 Q4	$399K	Buy	+5,259	New	+$399K	0.03%	513